The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often in Biotech.
Jifeng Ventures is a preeminent healthcare venture capital firm, which empowers enterprises and fuels innovation by providing a full range of value-added services and a global perspective.
Venture capitalShanghai, Chinajifengventures.comRounds from 2025-11-25 to 2026-11-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Phrontline Biopharma Phrontline Biopharma develops innovative antibody-drug conjugates (ADCs) focused on oncology therapies. | Series A Verified against 4 sources | $40M | 2026-11-13 | [ PART ] |
Phrontline Biopharma Phrontline Biopharma develops innovative antibody-drug conjugates (ADCs) focused on oncology therapies. | Pre-A |
| $60M |
| 2025-11-25 |
| [ PART ] |